CAS: 1392116-14-1
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | JD-5037 REF: AN-AG01EONNCAS: 1392116-14-1 | 98% | A consultar | Lun 13 May 24 |
 | JD-5037 REF: TM-T4453CAS: 1392116-14-1 | 98.87% | 43,00 €~538,00 € | Mar 21 May 24 |
 | JD 5037 REF: 3D-FJ166461CAS: 1392116-14-1 | Min. 95% | A consultar | Mar 25 Jun 24 |
Ref: AN-AG01EONN
| 5mg | 157,00 € | |
| 25mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
JD-5037
CAS:1392116-14-1
JD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM.
Fórmula:
C27H27Cl2N5O3S
Pureza:
98.87%
Forma y color:
Solid
Peso molecular:
572.51
Ref: TM-T4453
| 1mg | 43,00 € | |
| 2mg | 57,00 € | |
| 5mg | 94,00 € | |
| 10mg | 139,00 € | |
| 25mg | 241,00 € | |
| 50mg | 362,00 € | |
| 100mg | 538,00 € | |
| 1ml*10 (DMSO) | 104,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Mayo de 2024
JD 5037
CAS:1392116-14-1
JD 5037 is a monoclonal antibody that inhibits the binding of endocannabinoids to their receptors. …
Fórmula:
C27H27C12N5O3S
Pureza:
Min. 95%
Peso molecular:
645.73 g/mol
Ref: 3D-FJ166461
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 25 de Junio de 2024
